Screener
Upstream Bio, Inc. UPB Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Upstream Bio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The source filing: Upstream Bio, Inc.’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 7:10 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-343417
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Proceeds from issuance of common stock under stock plans | 1,048 | 612 |
| Payments of initial public offering costs | — | (34) |
| Net cash provided by financing activities | 3,131 | 578 |
| Net decrease in cash, cash equivalents and restricted cash | (22,181) | (280,434) |
| Cash, cash equivalents and restricted cash at beginning of period | 101,772 | 326,086 |
| Cash, cash equivalents and restricted cash at end of period | $79,591 | $45,652 |
| Cash, cash equivalents and restricted cash at end of period: | ||
| Cash and cash equivalents | $79,397 | $45,458 |
Item 1. Financial Statements.
FAQ
- What is Upstream Bio, Inc.'s net change in cash?
- Upstream Bio, Inc. (UPB) reported net change in cash of -$17.33M in Q2 2026.
- How has Upstream Bio, Inc.'s net change in cash changed year-over-year?
- Upstream Bio, Inc.'s net change in cash increased by 33.0% year-over-year, from -$25.85M to -$17.33M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.
Ask your AI about Upstream Bio, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude